Organisation paid for research Program year 2025 Source: CMS Open Payments

Medresearch Inc.

Neither a doctor nor a teaching hospital

Research payments

$461,533

277 payments

Through program year 2025, Medresearch Inc. is reported as receiving $461,533 in research payments, across 277 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$40,247	18
2024	Research	$33,126	19
2023	Research	$23,905	8
2022	Research	$15,923	8
2021	Research	$17,372	13
2020	Research	$108,403	57
2019	Research	$222,557	154

Breakdown

Who paid Research payments · program years 2019–2025

Bayer HealthCare Pharmaceuticals Inc. $346,032 222 payments
Janssen Research & Development, LLC $97,278 45 payments
Alnylam Pharmaceuticals Inc. $15,923 8 payments
Relypsa, Inc. $2,300 2 payments

Studies the money was for Research payments · program years 2019–2025

BAY 94-8862 ph 3 conventional in diab nephropathy $202,451 122 payments
BAY94-8862 ph 3 conventional in diabetic nephropathy $136,180 93 payments
70033093Acs3003 $57,031 27 payments
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) $40,247 18 payments
A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels $15,923 8 payments
Vericiguat in HFpEF $7,400 7 payments
Amber $2,300 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.